Perfil
Colin J. Meyer es Director de Investigación y Desarrollo, Vicepresidente Ejecutivo de Reata Pharmaceuticals, Inc. Se licenció en la Universidad de Virginia, se doctoró en el Centro Médico de la Universidad de Texas Southwestern y obtuvo un MBA en la Escuela de Negocios de la SMU-Cox.
Antiguos cargos conocidos de Colin Meyer.
| Empresas | Cargo | Fin |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 07/02/2022 |
Formación de Colin Meyer.
| University of Virginia | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
| SMU-Cox School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Colin Meyer
